Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP795606.RAHqAAnv42gGd9oWJlTEaUXNtfoJX6jq-y_BJkYapCgzg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP795606.RAHqAAnv42gGd9oWJlTEaUXNtfoJX6jq-y_BJkYapCgzg130_assertion type Assertion NP795606.RAHqAAnv42gGd9oWJlTEaUXNtfoJX6jq-y_BJkYapCgzg130_head.
- NP795606.RAHqAAnv42gGd9oWJlTEaUXNtfoJX6jq-y_BJkYapCgzg130_assertion wasGeneratedBy ECO_0000203 NP795606.RAHqAAnv42gGd9oWJlTEaUXNtfoJX6jq-y_BJkYapCgzg130_provenance.
- NP795606.RAHqAAnv42gGd9oWJlTEaUXNtfoJX6jq-y_BJkYapCgzg130_assertion wasDerivedFrom befree-2016 NP795606.RAHqAAnv42gGd9oWJlTEaUXNtfoJX6jq-y_BJkYapCgzg130_provenance.
- NP795606.RAHqAAnv42gGd9oWJlTEaUXNtfoJX6jq-y_BJkYapCgzg130_assertion SIO_000772 20179196 NP795606.RAHqAAnv42gGd9oWJlTEaUXNtfoJX6jq-y_BJkYapCgzg130_provenance.
- NP795606.RAHqAAnv42gGd9oWJlTEaUXNtfoJX6jq-y_BJkYapCgzg130_assertion evidence source_evidence_literature NP795606.RAHqAAnv42gGd9oWJlTEaUXNtfoJX6jq-y_BJkYapCgzg130_provenance.
- NP795606.RAHqAAnv42gGd9oWJlTEaUXNtfoJX6jq-y_BJkYapCgzg130_assertion description "[FGFR1 amplification drives endocrine therapy resistance and is a therapeutic target in breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP795606.RAHqAAnv42gGd9oWJlTEaUXNtfoJX6jq-y_BJkYapCgzg130_provenance.